Cardiotoxicity
Cardiotoxicity
Explore linked clinical trials. Standard reference: MESH:M059272873 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cardiac Biomarkers in Patients Receiving Immune Checkpoint Inhibitors (PRIME-ICI) | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury | Not yet recruiting | Not stated | 2026-10-08 | NCT07864727 | |
| Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) | Arrhythmias, Cardiac, Blood Protein Disorders, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Ventricular Dysfunction, Ventricular Dysfunction, Left, breast cancer, breast disorder, breast neoplasm, cancer, cardiovascular disorder, heart disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, injury, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, radiation injury, skin disorder, vascular disorder, vascular hemostatic disease | Not yet recruiting | Not applicable | 2026-10-06 | NCT07776964 | |
| Novel On-body Evaluation of Cardiac Health for Oncology | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, injury, radiation injury | Enrolling by invitation | Not stated | 2026-10-05 | NCT07158450 | |
| Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, radiation injury, respiratory system disorder, respiratory tract neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT06332131 | |
| Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors | Arrhythmias, Cardiac, B-cell chronic lymphocytic leukemia, Cardiotoxicity, Chemically-Induced Disorders, Chronic Disease, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, hematologic disorder, hypertensive disorder, immune system disorder, immunoproliferative disorder, injury, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, radiation injury, vascular disorder | Enrolling by invitation | Not stated | 2026-10-05 | NCT06211413 | |
| Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT05036252 | |
| Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, radiation injury, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-10-05 | NCT04305613 | |
| Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury | Active, not recruiting | Phase 4 | 2026-10-02 | NCT04939883 | |
| Cardioprotection Effect of Linagliptin | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Not yet recruiting | Phase 3 | 2026-10-01 | NCT07852546 | |
| Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. | Arrhythmias, Cardiac, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, heart disorder, hypertensive disorder, injury, lung disorder, myocardial ischemia, pulmonary hypertension, radiation injury, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-09-25 | NCT07157670 | |
| Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, immune system disorder, immunoproliferative disorder, injury, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma, radiation injury, skin disorder | Not yet recruiting | Phase 1 | 2026-09-24 | NCT07838649 | |
| Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma | B-cell neoplasm, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, diffuse large B-cell lymphoma, heart disorder, heart failure, histiocytosis, immune system disorder, immunoproliferative disorder, injury, interdigitating dendritic cell sarcoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, malignant histiocytosis, neoplasm, radiation injury | Recruiting | Phase 3 | 2026-09-23 | NCT06220032 | |
| Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Recruiting | Not stated | 2026-09-16 | NCT07588425 | |
| Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, radiation injury, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-15 | NCT07761910 | |
| Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer-related condition, cardiovascular disorder, heart disorder, heart failure, injury, metabolic disease, radiation injury, vascular disorder | Recruiting | Not stated | 2026-09-11 | NCT03882580 | |
| TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Recruiting | Not applicable | 2026-08-13 | NCT06310330 | |
| The CARDIOPROTECT Trial | B-cell neoplasm, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, diffuse large B-cell lymphoma, heart disorder, immune system disorder, immunoproliferative disorder, injury, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, radiation injury | Recruiting | Phase 2 | 2026-07-27 | NCT07654426 | |
| The STOP-MED CTRCD Trial | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury | Recruiting | Phase 4 | 2026-07-07 | NCT06183437 | |
| Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT03934905 | |
| Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity. | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury | Recruiting | Not stated | 2026-06-23 | NCT07663357 | |
| Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Active, not recruiting | Phase 3 | 2026-06-16 | NCT05271162 | |
| Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Active, not recruiting | Phase 4 | 2026-06-16 | NCT04928261 | |
| JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury, skin disorder | Recruiting | Not applicable | 2026-06-15 | NCT06930521 | |
| Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Recruiting | Not stated | 2026-06-03 | NCT02772367 | |
| AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor | Arrhythmias, Cardiac, Atrial Remodeling, Cardiomegaly, Cardiotoxicity, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Consciousness Disorders, Drug-Related Side Effects and Adverse Reactions, Infarction, Necrosis, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Syncope, Unconsciousness, Ventricular Dysfunction, Ventricular Dysfunction, Left, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, heart failure, heart valve disorder, hereditary disease, injury, ischemic disease, laminopathy, myocardial infarction, myocardial ischemia, nervous system disorder, radiation injury, vascular disorder | Recruiting | Not stated | 2026-06-01 | NCT06699056 |